165 results match your criteria Photodynamic Therapy for the Dermatologist


An Update on Topical Photodynamic Therapy for Clinical Dermatologists.

J Dermatolog Treat 2019 Jan 16:1-37. Epub 2019 Jan 16.

b Veterans Affairs Medical Center , Brooklyn , NY , USA.

Introduction: Photodynamic therapy (PDT) involves the application of a topical photosensitizer, irradiation with light, and oxygen to produce cytotoxic reactive oxygen species that selectively destroy damaged cells while leaving normal skin intact. Topical PDT is a commonly used treatment for non-melanoma skin cancers (NMSCs) due to its excellent clearance rate and cosmetic outcomes. However, PDT is emerging as an off-label treatment modality for many dermatological conditions. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1
Publisher Site
http://dx.doi.org/10.1080/09546634.2019.1569752DOI Listing
January 2019
6 Reads

Photodynamic therapy in dermatology.

Authors:
Lasse R Braathen

G Ital Dermatol Venereol 2018 12;153(6):763

Dermatologist, Bern, Switzerland -

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.18.06210-7DOI Listing
December 2018
1 Read

British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018.

Br J Dermatol 2018 Dec 2. Epub 2018 Dec 2.

British Association of Dermatologists, Willan House, 4 Fitzroy Square, London, W1T 5HQ, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.17309DOI Listing
December 2018
1 Read

Adverse effects of topical photodynamic therapy: a consensus review and approach to management.

Br J Dermatol 2018 Sep 5. Epub 2018 Sep 5.

British Association of Dermatologists, London, U.K.

Background: Topical photodynamic therapy (PDT) is widely used to treat superficial nonmelanoma skin cancer and dysplasia, and is generally well tolerated. However, as with all treatments, adverse effects may occur and awareness may facilitate approaches to prevention and management.

Objectives: To review the available evidence relating to the adverse effects of topical PDT, to help inform recommendations in updated clinical guidelines produced by the British Association of Dermatologists and British Photodermatology Group, and the efficacy of preventative and therapeutic approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.17131DOI Listing
September 2018
6 Reads

Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update.

Lasers Med Sci 2018 Sep 14;33(7):1431-1439. Epub 2018 Jul 14.

International Hair Research Foundation (IHRF), Milan, Italy.

Benefit deriving from the use of light is known since ancient time, but, only in the last decades of twentieth century, we witnessed the rapid expansion of knowledge and techniques. Light-emitted diode (LED)-based devices represent the emerging and safest tool for the treatment of many conditions such as skin inflammatory conditions, aging, and disorders linked to hair growth. The present work reviews the current knowledge about LED-based therapeutic approaches in different skin and hair disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10103-018-2584-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133043PMC
September 2018
3 Reads

Female Genital Itch.

Dermatol Clin 2018 Jul 26;36(3):225-243. Epub 2018 Apr 26.

Department of Dermatology, Wake Forest University School of Medicine, 4618 Country Club Road, Winston-Salem, NC 27104, USA. Electronic address:

Vulvar pruritus is a common complaint among young girls and women presenting to primary care physicians, gynecologists, and dermatologists. Female genital itch is especially disruptive because of its interference with sexual function and intimacy. Causes of vulvar itch are vast and may be inflammatory, environmental, neoplastic, or infectious, often with several causes coexisting simultaneously. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07338635183001
Publisher Site
http://dx.doi.org/10.1016/j.det.2018.02.006DOI Listing
July 2018
10 Reads

Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.

Br J Dermatol 2018 Dec 9;179(6):1277-1296. Epub 2018 Sep 9.

Photobiology Unit, Dermatology Centre, The University of Manchester & Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, U.K.

Background: Topical photodynamic therapy (PDT) is an established treatment option for low-risk basal cell carcinoma (BCC).

Objectives: To compare efficacy, cosmesis and tolerability of PDT for BCC with alternative treatments.

Methods: MEDLINE, PubMed, Embase and CENTRAL databases were searched from inception until 1 September 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.16838DOI Listing
December 2018
1 Read

Photodynamic therapy with topical photosensitizers in mucosal and semimucosal areas: Review from a dermatologic perspective.

Photodiagnosis Photodyn Ther 2018 Sep 15;23:119-131. Epub 2018 Apr 15.

University of Florence School of Health Sciences, Department of Surgical and Translational Medicine, Section of Dermatology, P. Palagi Hospital, Viale Michelangelo 41, 50125, Florence, Italy.

Photodynamic Therapy is a procedure based on the interaction between a Photosensitizer, a light source with a specific wavelength and oxygen. The aim of this review is to provide a brief and updated analysis of scientific reports on the use of PDT with topical PS in the management of oncological, infectious, and inflammatory disorders involving mucosal and semimucosal areas, with a specific focus on diseases of dermatologic interest. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15721000173046
Publisher Site
http://dx.doi.org/10.1016/j.pdpdt.2018.04.005DOI Listing
September 2018
8 Reads

Photodynamic Therapy Activated by Intense Pulsed Light in the Treatment of Nonmelanoma Skin Cancer.

Biomedicines 2018 Feb 7;6(1). Epub 2018 Feb 7.

Skin Center, Dermo-Aesthetic Lasers Centers, 67051 Avezzano, Italy.

Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) has proven to be a highly effective conservative method for the treatment of actinic keratosis (AK), Bowen's disease (BD), and superficial basal cell carcinoma (sBCC). PDT is traditionally performed in association with broad-spectrum continuous-wave light sources, such as red or blue light. Recently, intense pulsed light (IPL) devices have been investigated as an alternative light source for PDT in the treatment of nonmelanoma skin cancers (NMSC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biomedicines6010018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874675PMC
February 2018
4 Reads

Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.

J Drugs Dermatol 2017 Mar;16(3):260-264

Dermatologists treat actinic keratosis (AK) primarily because these lesions have the potential to progress to invasive squamous cell carcinoma. Patients, on the other hand, generally seek treatment to remove the lesions and achieve an improved appearance of their skin following treatment. In selecting a treatment option for AK, dermatologists should consider post-treatment cosmesis, because cosmetic outcomes differ across AK treatments. Read More

View Article

Download full-text PDF

Source
March 2017
19 Reads

British Association of Dermatologists' guidelines for the care of patients with actinic keratosis 2017.

Br J Dermatol 2017 Jan;176(1):20-43

Portsmouth Dermatology Centre, Portsmouth Hospitals NHS Trust, Portsmouth, PO3 6AD, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.15107DOI Listing
January 2017
12 Reads

The Two Faces of Fractionated Photodynamic Therapy: Increasing Efficacy With Light Fractionation or Adjuvant Use of Fractional Laser Technology.

J Drugs Dermatol 2016 Nov;15(11):1324-1328

"Fractionated photodynamic therapy (PDT)" is a new term being used by dermatologists to describe advances in PDT technology including fractionated light or the adjuvant use of fractional lasers. Although dermatologists have used PDT since the early 1990s for the treatment of photodamage and precancerous lesions, newer developments in technology have allowed for the treatment of non-melanoma skin cancers (NMSCs), in ammatory disorders, and even uses in the eld of anti-aging. Recent developments in fractionated light therapy have allowed for PDT with dark intervals and two-fold illumination schemes to increase cellular damage and apoptosis. Read More

View Article

Download full-text PDF

Source
November 2016
8 Reads

Long-Pulsed 1064-nm Nd:YAG Laser for the Treatment of Onychomycosis.

Photomed Laser Surg 2017 Apr 30;35(4):213-216. Epub 2016 Dec 30.

5 Department of Health Sciences, University of Catanzaro , Catanzaro, Italy .

Objective: The aim of this study is to evaluate the efficacy of long-pulsed 1064-nm Nd:YAG laser in penetrating tissue and targeting the fungal overgrowth in the nail plate.

Background: Onychomycosis is the most frequent nail disorder. Current treatments include oral and topical antifungal agents, photodynamic therapy, and surgical approaches such as mechanical, chemical, or surgical nail avulsion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pho.2016.4153DOI Listing
April 2017
5 Reads

Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists.

Br J Dermatol 2017 Jun 16;176(6):1617-1623. Epub 2017 Apr 16.

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K.

Background: Little is known about U.K. dermatologists' treatment approaches towards adult patients with recalcitrant moderate-to-severe atopic eczema. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.15235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516126PMC

Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.

J Dermatolog Treat 2017 Aug 13;28(5):431-442. Epub 2016 Nov 13.

n Department of Dermatology , University of Modena and Reggio Emilia , Modena , Italy.

Actinic keratosis (AK) is a chronic skin disease in which multiple clinical and subclinical lesions co-exist across large areas of sun-exposed skin, resulting in field cancerisation. Lesions require treatment because of their potential to transform into invasive squamous cell carcinoma. This article aims to provide office-based dermatologists and general practitioners with simple guidance on AK treatment in daily clinical practice to supplement existing evidence-based guidelines. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09546634.2016.1
Publisher Site
http://dx.doi.org/10.1080/09546634.2016.1254328DOI Listing
August 2017
50 Reads

[The effect of drugs used in treatment of skin disorders on visual system].

Pol Merkur Lekarski 2016 Apr;40(238):269-72

Department of Dermatology, Venerology and Pediatric Dermatology, Medical University of Lublin, Poland.

Drugs with side effects affecting vision are often used in the treatment of skin disorders. The study evaluated principal groups of medicines which may negatively influence vision and the eye itself. Antimalaric drugs may cause a number of disorders of vision and a diagnosed retinophaty is an absolute contraindication. Read More

View Article

Download full-text PDF

Source
April 2016
4 Reads

Adjunct use of optical coherence tomography increases the detection of recurrent basal cell carcinoma over clinical and dermoscopic examination alone.

Photodiagnosis Photodyn Ther 2016 Jun 22;14:178-84. Epub 2016 Apr 22.

Zaeland University Hospital, Department of Dermatology, Roskilde, Denmark.

Background: Basal cell carcinoma (BCC) is a locally destructive form of skin cancer, mainly affecting Caucasians. In the last few years non-surgical treatments of BCC have become widely used and non-invasive methods for treatment monitoring and follow-up are therefore becoming increasingly warranted. The objective of this study was to investigate the utility of adjunct use of non-invasive optical coherence tomography (OCT) imaging for the detection of recurrent BCC over clinical and dermoscopic examination alone, in a real-world setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2016.04.010DOI Listing
June 2016
5 Reads

Photodynamic therapy for the treatment of different severity of acne: A systematic review.

Photodiagnosis Photodyn Ther 2016 Jun 16;14:191-9. Epub 2016 Apr 16.

Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, PR China, PR China. Electronic address:

Introduction: Acne, a disease of pilosebaceous unit, is a common dermatologic disorder affecting about 80%-95% of people in both genders in adulthood. The available treatment options are conventional topical and/or oral medications, which are associated with adverse effects, partial response only, contraindications and reoccurrences. This necessitates the need for the introduction of novel treatment for improving acne lesions. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15721000163003
Publisher Site
http://dx.doi.org/10.1016/j.pdpdt.2016.04.005DOI Listing
June 2016
4 Reads

Intense pulsed light versus photodynamic therapy using liposomal methylene blue gel for the treatment of truncal acne vulgaris: a comparative randomized split body study.

Arch Dermatol Res 2016 May 18;308(4):263-8. Epub 2016 Mar 18.

Cairo Hospital for Dermatology and Venereology (Al-Haud Al-Marsoud), Cairo, Egypt.

Acne vulgaris is an extremely common skin condition. It often leads to negative psychological consequences. Photodynamic therapy (PDT) using intense pulsed light has been introduced for effective treatment of acne. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00403-016-1639-6DOI Listing
May 2016
5 Reads

Pyogenic granuloma in a patient with psoriasis successfully treated by 5-aminolevulinic acid photodynamic therapy: A case report.

Exp Ther Med 2016 Jan 27;11(1):345-347. Epub 2015 Nov 27.

Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.

Pyogenic granuloma (PG) is an acquired benign vascular tumor of unknown etiology. In the present case report, PG was detected in a 49-year-old Chinese male patient with chronic plaque psoriasis. The psoriasis lesions on the finger where the granuloma had developed had been scratched excessively, as declared by the patient. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2015.2899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727201PMC
January 2016
8 Reads

Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.

J Eur Acad Dermatol Venereol 2016 Jan 9;30(1):8-15. Epub 2015 Nov 9.

Department of Dermatology, Molholm Hospital, Vejle, Denmark.

Conventional PDT (c-PDT) is a widely used and approved non-invasive treatment for actinic keratosis (AK). Recent clinical, histological and immunohistochemical observations have shown that c-PDT with methyl aminolevulinate (MAL) may also partially reverse the signs of photodamage. However, pain and the need for special light source equipment are limiting factors for its use, especially in the treatment of large areas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.13327DOI Listing
January 2016
10 Reads

Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.

Photodermatol Photoimmunol Photomed 2016 Mar 9;32(2):81-7. Epub 2015 Dec 9.

Santiago Medical Institute, Santiago, Chile.

Although conventional photodynamic therapy (c-PDT) using methyl aminolevulinate cream (MAL) is effective for the treatment of grade I-II facial and scalp actinic keratosis (AK), it is associated with treatment-related pain for some patients. Daylight-mediated PDT (DL-PDT) has shown similar efficacy to c-PDT, was nearly painless, and was well tolerated. Overall, DL-PDT effectively treats AK and offers a simpler and better tolerated treatment option than c-PDT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/phpp.12221DOI Listing
March 2016
7 Reads

[VISIBLE LIGHT AND HUMAN SKIN (REVIEW)].

Georgian Med News 2015 Sep(246):46-53

Tbilisi State Medical University; I. Javakhishvili Tbilisi State University, Georgia.

Biological effect of a visible light depends on extend of its property to penetrate into the tissues: the greater is a wavelength the more is an effect of a radiation. An impact of a visible light on the skin is evident by wave and quantum effects. Quanta of a visible radiation carry more energy than infrared radiation, although an influence of such radiation on the skin is produced by the light spectrum on the boarder of the ultraviolet and the infrared rays and is manifested by thermal and chemical effects. Read More

View Article

Download full-text PDF

Source
September 2015
3 Reads

Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.

Int J Dermatol 2016 Mar 14;55(3):309-16. Epub 2015 Aug 14.

Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Objectives: The incidence of actinic keratosis (AK) is increasing, and several treatment options are available. The aim of this study was to describe clinical characteristics and treatment patterns in patients with AK treated by Danish dermatologists.

Methods: A multicenter, non-interventional, cross-sectional study was conducted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.12874DOI Listing
March 2016
6 Reads

Imiquimod and Photodynamic Therapy Are Useful in the Treatment of Porokeratosis in Children with Bone Marrow Transplantation.

Pediatr Dermatol 2015 Nov-Dec;32(6):e291-3. Epub 2015 Jul 29.

Dermatology Service, Hospital San Jorge, Huesca, Spain.

Porokeratosis is an uncommon disorder that affects keratinization. Immunosuppression may favor the development of porokeratotic lesions. Patients who receive allogenic transplants represent a therapeutic challenge to dermatologists. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.12654DOI Listing
September 2016
6 Reads

Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.

Actas Dermosifiliogr 2015 Oct 24;106(8):623-31. Epub 2015 Jun 24.

Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España.

Introduction: Daylight-mediated photodynamic therapy (PDT) is a new type of PDT that is as effective as conventional PDT in grade 1 and 2 actinic keratosis but with fewer adverse effects, resulting in greater efficiency. The climatic conditions in the Iberian Peninsula require an appropriately adapted consensus protocol.

Objective: We describe a protocol for the treatment of grade 1 and 2 actinic keratosis with daylight-mediated PDT and methyl aminolevulinate (MAL) adapted to the epidemiological and clinical characteristics of Spanish and Portuguese patients and the climatic conditions of both countries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ad.2015.06.001DOI Listing
October 2015
7 Reads

Treatment of basal cell carcinoma in Scandinavia: evidence or eminence based?

Int J Dermatol 2015 Sep 6;54(9):1030-3. Epub 2015 Feb 6.

Department of Dermatology, Karlskoga Hospital, Karlskoga, Sweden.

Background: Basal cell carcinoma (BCC) is a locally destructive form of skin cancer, mainly affecting Caucasians. There are multiple treatment options for BCC, with excisional surgery being most widely used. Choice of treatment may be dependent on clinical guidelines, local therapeutic traditions, and/or personal experience. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.12599DOI Listing
September 2015
3 Reads

Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus.

J Eur Acad Dermatol Venereol 2015 Sep 28;29(9):1718-23. Epub 2015 Jan 28.

Dermatology, Bern, Im Holenacker 16, CH-3063, Ittigen, Switzerland.

Introduction: Daylight-mediated photodynamic therapy has been shown to be an effective therapy for actinic keratoses (AKs) and a simple and tolerable treatment procedure in three randomized Scandinavian studies and two recent Phase III randomized controlled studies in Australia and Europe.

Objectives: To establish consensus recommendations for the use of daylight photodynamic therapy (DL-PDT) using topical methyl aminolaevulinate (MAL) in European patients with AKs.

Methods: The DL-PDT consensus recommendations were developed on behalf of the European Society for Photodynamic Therapy in Dermatology and comprised of 10 dermatologists from different European countries with experience in how to treat AK patients with PDT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.12974DOI Listing
September 2015
59 Reads

Phototherapy for atopic dermatitis.

Indian J Dermatol Venereol Leprol 2015 Jan-Feb;81(1):10-5

Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Background: The aim of these guidelines is to review the available published literature regarding the effectiveness of phototherapy and photochemotherapy in atopic dermatitis and put forward recommendations regarding their use in atopic dermatitis.

Materials And Methods: A literature search was performed to collect data from PubMed, EMBASE, and the Cochrane Library published till March 2014. Keywords used were "phototherapy", "photochemotherapy", "NB-UVB", "BBUVB", "PUVA", "UVA1", "atopic dermatitis", and "atopic eczema". Read More

View Article

Download full-text PDF

Source
http://www.ijdvl.com/text.asp?2015/81/1/10/148557
Publisher Site
http://dx.doi.org/10.4103/0378-6323.148557DOI Listing
September 2015
5 Reads

Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.

Curr Probl Dermatol 2015 18;46:115-21. Epub 2014 Dec 18.

Hautzentrum Köln (Cologne Dermatology), Cologne, Germany.

The incidence of non-melanoma skin cancer (NMSC), including actinic keratosis (AK), squamous cell carcinoma (SCC), Bowen's Disease (BD) and basal cell carcinoma (BCC), is increasing. UVA and UVB radiation lead to genetic alterations in keratinocytes, which eventually result in skin cancer. In the concept of field cancerization of the skin, genetically altered keratinocytes accumulate over an area exposed to UV radiation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000366547DOI Listing
September 2015
5 Reads

Lmax and imiquimod 3.75% in daily clinical practice.

Authors:
G Gupta

J Eur Acad Dermatol Venereol 2015 Jan;29 Suppl 1:15-8

Department of Dermatology, Monklands Hospital, Airdrie, Lanarkshire, UK.

Background: Lmax, the maximum lesion count during treatment, is a new concept for evaluating the efficacy of field-directed treatments for actinic keratosis (AK) against clinical and subclinical lesions. Imiquimod 3.75% is a field-directed AK treatment, which can detect and clear clinical and subclinical lesions across an entire sun-exposed field such as the full face or balding scalp. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.12829DOI Listing
January 2015
1 Read

Photochemotherapy (PUVA) in psoriasis and vitiligo.

Indian J Dermatol Venereol Leprol 2014 Nov-Dec;80(6):497-504

Department of Dermatology and Venereology, Kasturba Medical College, Manipal University, Manipal, India.

Phototherapy with photochemotherapy (PUVA) is a well-known and well-studied modality for the treatment of psoriasis, which involves systemic or topical administration of chemicals known as psoralens and administration of ultraviolet light in increasing dosages after requisite time gap. PUVA is also used in the treatment of widespread vitiligo with moderately good results, though it is being surpassed by ultraviolet B (UVB), which is equally or slightly more efficacious with fewer side effects. PUVA induces repigmentation by varying mechanisms such as stimulation of melanogenesis, immunomodulation and activation of growth factors, though the exact mechanism is still speculative. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0378-6323.144143DOI Listing
May 2016
3 Reads

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014.

Br J Dermatol 2014 Oct 1;171(4):696-712. Epub 2014 Oct 1.

Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 OQQ, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.13310DOI Listing
October 2014
7 Reads

Photodynamic Therapy with 5% δ-Aminolevulinic Acid is Safe and Effective Treatment of Acne Vulgaris in Japanese Patients.

Laser Ther 2014 Jul;23(2):115-20

Department of Dermatology, Nippon Medical School, Japan.

Background And Aims: Photodynamic therapy with aminolevulinic acid (ALA-PDT) is effective therapy for acne vulgaris; however, relatively strong side effects limit its wide usage. We have previously demonstrated that ALA-induced protoporphyrin IX distribution with lower concentrations and shorter contact time of ALA resulted in focused damage in sebaceous glands in vivo. We have formulated a protocol for ALA-PDT using 5% ALA with 2 hours contact time. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5978/islsm.14-OR-09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112280PMC
July 2014
4 Reads

[Lichen sclerosus--clinical and therapeutic aspects].

Akush Ginekol (Sofiia) 2014 ;53(1):35-9

Lichen sclerosus (LS) is a lymphocyte-mediated inflammatory dermatosis with a characteristic location (85-98%) in the anogenital region. The authors point out the main features in the epidemiology and clinical presentation of the disease and the possible approach to neoplastic development. Expanded differential diagnosis of LS sparked not only dermatologists but also gynecologists, urologists and GPs. Read More

View Article

Download full-text PDF

Source
September 2014
4 Reads

Photodynamic therapy using a new formulation of 5-aminolevulinic acid for wrinkles in Asian skin: A randomized controlled split face study.

J Dermatolog Treat 2015 Jun 9;26(3):246-51. Epub 2014 Jul 9.

Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Korea.

Background: Photodynamic therapy (PDT) with intense pulsed light (IPL) was proven effective for photorejuvenation. Recently, a new formulation of 0.5% 5-aminolevulinic acid (ALA) liposomal spray has been available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/09546634.2014.933163DOI Listing
June 2015
6 Reads

Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis.

G Ital Dermatol Venereol 2014 Apr;149(2):193-8

Department of Dermatology University of L'Aquila, L'Aquila, Italy -

Aim: We report concerns toward prescription adherence and treatment effectiveness in the clinical management of actinic keratosis (AK) in Italy.

Methods: We carried out a cross-sectional web-based survey among Italian dermatologists across Italy. Physicians were asked to answer a self-administered questionnaire about their concerns around AK therapy and barriers to patients' adherence. Read More

View Article

Download full-text PDF

Source
April 2014
5 Reads

Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.

G Ital Dermatol Venereol 2014 Apr;149(2):185-92

Department of General Oncological Dermatology L'Aquila University, L'Aquila, Italy -

Aim: We report dermatologists' opinions and clinical practice patterns about clinical factors driving decision making in the management of actinic keratosis (AK) in Italy.

Methods: We carried out a cross-sectional survey among 33 Italian dermatologists. Physicians were asked to report their management choices in consecutive patients with AK seen at their practice within 2 weeks since study initiation. Read More

View Article

Download full-text PDF

Source
April 2014
5 Reads

Update of the European guidelines for basal cell carcinoma management.

Eur J Dermatol 2014 May-Jun;24(3):312-29

Département de Dermatologie, Hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75017 Paris, France.

Background: European guidelines for the management of basal cell carcinoma (BCC) prepared by the former BCC subcommittee of the Guidelines Committee of the European Dermatology Forum (EDF) were published in 2006.

Objectives: To present updated guidelines that include consensual expert definitions on various BCC types, prognosis and risk factors for BCC as well as review recommendations for diagnosis and treatment reflecting current published evidence.

Methods: These guidelines (S1 type) were prepared by the new BCC subgroup of the European Dermatology Forum (EDF)'s Guidelines Committee through extensive literature review (up to 2012) and expert experience; they were extensively discussed within the EDF subcommittee and approved by peer reviewers of the EDF. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2014.2271DOI Listing
May 2015
43 Reads

Reliability of solar keratosis clinical diagnosis: A prospective study.

Australas J Dermatol 2015 May 17;56(2):e49-52. Epub 2014 Mar 17.

Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.

Usually solar keratoses (SK) are diagnosed clinically. However other diseases may clinically present as erythematous macules, papules or patches on sun-exposed areas; therefore the histopathology remains the gold standard diagnostic tool. Our study, which assessed the efficacy of photodynamic therapy (PDT), showed that one in 20 clinically diagnosed SK lesions grade I-II identified by board-certified dermatologists were rosacea and only one in 40 were malignant lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12095DOI Listing
May 2015
3 Reads

Perioral dermatitis: a review of the condition with special attention to treatment options.

Am J Clin Dermatol 2014 Apr;15(2):101-13

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Sor Kor 11th Building, Pathumwan, Bangkok, Thailand,

Perioral dermatitis is a common acneiform facial eruption found in both adults and children. Its variants are periorificial and granulomatous periorificial dermatitis. The etiology of perioral dermatitis remains unknown; however, topical corticosteroid use on the face commonly precedes the manifestation of this condition. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-014-0067-7DOI Listing
April 2014
2 Reads

Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.

J Eur Acad Dermatol Venereol 2014 Sep 11;28(9):1141-9. Epub 2014 Mar 11.

Department of Dermato cancerology, University Hospital Hotel Dieu, Nantes, France.

Background: Actinic keratoses (AK) are common photo-induced cutaneous lesions that may progress to invasive squamous-cell carcinoma and serve as a risk marker for skin cancer. Although numerous studies present the various therapeutic options for AK, publications that can be used to pragmatically guide dermatologists in their daily practice are limited. National and international guidelines have been published, however, they are based on clinical trials with highly selected patient populations and do not always capture the range of patients seen in everyday practice. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.12434DOI Listing
September 2014
7 Reads

Drug-induced photoallergic and phototoxic reactions - an update.

Expert Opin Drug Saf 2014 Mar;13(3):321-40

New York Presbyterian Hospital, Weill Cornell Medical College, Department of Dermatology , New York, NY 10021 , USA

Introduction: Photoallergic and phototoxic medications continue to be an important concern for dermatologists. In the last 5 years, the list of phototoxic and photoallergic medications has expanded, as well as the testing tools used to screen for potential allergy. Currently available testing methods include the photoprick, photoscratch and illuminated intracutaneous tests. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2014.885948DOI Listing
March 2014
8 Reads

Lasers and laser-like devices: part two.

Australas J Dermatol 2014 Feb 11;55(1):1-14. Epub 2013 Nov 11.

Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales; University of Sydney, Camperdown, New South Wales.

Part two of this review series evaluates the use of lasers and laser-like devices in dermatology based on published evidence and the collective experience of the senior authors. Dermatologists can laser-treat a wide range of dermatoses, including vascular, pigmentary, textural, benign proliferative and premalignant conditions. Some of these conditions include vascular malformation, haemangioma, facial telangiectases, café-au-lait macules, naevi of Ota, lentigines, acne scarring, rhytides, rhinophyma and miscellaneous skin lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12111DOI Listing
February 2014
3 Reads

Prolonged adverse events following photodynamic therapy: regulatory implications.

J Drugs Dermatol 2014 Jan;13(1):62-6

Objective: To determine whether field photodynamic therapy (PDT) of actinic keratoses (AKs) using a novel preparation of 5-aminolevulonic acid (ALA) would result in fewer subsequent invasive skin cancers developing on the face.

Design: A prospective multi-center randomized controlled trial. The protocol was approved by the Bond University Human Research Ethics Committee in accord with the TGA's Clinical Trial Notification Scheme. Read More

View Article

Download full-text PDF

Source
January 2014
3 Reads

Psoralen-ultraviolet A treatment with Psoralen-ultraviolet B therapy in the treatment of psoriasis.

Pak J Med Sci 2013 May;29(3):758-61

Dr. Najam-us-Saher, Consultant Dermatologist, Zainab Panjwani Memorial Hospital, Karachi, Pakistan.

Objective: To compare the conventional psoralen-ultraviolet A treatment with psoralen-ultraviolet B therapy in the treatment of psoriasis.

Methodology: We studied 50 patients of plaque type psoriasis who were selected to receive either conventional psoralen-ultraviolet A or psoralen-ultraviolet B treatment.

Results: There was no significant difference between the two treatment groups in the number of patients whose skin cleared of psoriasis or the number of exposures required for clearance. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809278PMC
May 2013
3 Reads

British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014.

Br J Dermatol 2014 Feb;170(2):245-60

Stirling Community Hospital, Stirling, FK8 2AU, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.12766DOI Listing
February 2014
5 Reads

Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.

Am J Clin Dermatol 2013 Aug;14(4):273-7

Division of Dermatology, University of California-Habor Medical Center, Torrance, CA, USA.

Actinic (solar) keratoses (AK) have the potential for malignant transformation and are the second most common diagnosis in dermatologic practices. No well-established clinical criteria are available to determine which AK are more likely to undergo malignant transformation; therefore, many dermatologists utilize field-directed approaches to treat all visible and subclinical AK on an affected skin surface. Current topical therapeutic agents require lengthy treatment regimens and are less well tolerated than many newer and investigational agents. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-013-0023-yDOI Listing
August 2013
3 Reads

Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.

J Eur Acad Dermatol Venereol 2014 May 13;28(5):626-32. Epub 2013 Apr 13.

Hôpital Saint-Louis, Paris, France.

Background: Patients with Gorlin syndrome develop multiple basal cell carcinomas (BCC), for which treatment is often difficult. Methylaminolevulinate-photodynamic therapy (MAL-PDT) is approved for the treatment of superficial and nodular BCCs in Canada and several European countries.

Objectives: To establish consensus recommendations for the use of MAL-PDT in patients with Gorlin syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.12150DOI Listing
May 2014
6 Reads